UTHSC In the Media


Organizers urge black women to register for event on breast health

In the Media Icon

African-American women from Memphis and the West Tennessee area are invited to register for a breast cancer summit at the University of Tennessee Health Science Center on Feb. 7, from 10 a.m. to 2 p.m. . . UTHSC’s Research Center on Health Disparities, Equity and the Exposome (RCHDEE) has convened a Breast Cancer Awareness and… Read More


Anti-radiation drug could work days after exposure, says Dr. Tigyi

In the Media Icon

Cells try to repair damage to their DNA after radiation exposure, says Gábor Tigyi at the University of Tennessee Health Science Center


UTHSC Professor Honored by National Academy of Inventors

The Daily News

Duane Miller, professor and chair of the Department of Pharmaceutical Sciences in the College of Pharmacy at the University of Tennessee Health Science Center, has been named a fellow of the National Academy of Inventors.


Fighting Breast Cancer Requires Awareness

The Daily News

“We’re the last to get screened, the last to get treated, and because of that we tend to die earlier,” said Patricia Matthews-Juarez, PhD, and co-director of the University of Tennessee Health Science Center’s Research Center on Health Disparities, Equity and the Exposome.


Dr. Jay SoloRio joins AVH Surgical Associates

In the Media Icon

Dr. SoloRio earned his Doctor of Medicine from the University of Tennessee Center for the Health Sciences in Memphis.


Newly insured flood emergency room

In the Media Icon

The residency is part of an expansion of an agreement between Saint Thomas Health and the University of Tennessee Health Science Center.


Nuclear radiation drugs offer protection up to 3 days after exposure to fallout

In the Media Icon

Scientists from the University of Tennessee Health Science Centre have found one drug candidate – DBIBB – protected mice effectively.


Un medicamento pionero es capaz de frenar los daños de la radiación

In the Media Icon

Se trata de un fármaco desarrollado a partir de un compuesto natural que se produce en la sangre y que favorece la cicatrización, según explica el líder de esta investigación, Gábor Tigyi. “También es generado por cánceres agresivos resistentes a la radioterapia contra los tumores”, afirma este investigador del Centro de Ciencias de la Salud… Read More